Personalized medicine is gaining prominence in many areas of clinical research. In particular, recent advances in whole genome sequencing have led to the characterization of genes conferring disease risk or likelihood of response to treatment, allowing the development of individualized risk assessment and therapy. In light of the progress in patient-tailored medicine across many therapeutic… Read more »
The Next-Generation Sequencing (NGS) conference organized by SMi was held in London on 17 and 18 September and Genome Medicine was there. As the Personalized Medicine Head of Unit at the European Commission, Patrick Kolar, pointed out in his opening remarks, the exponential growth in this field has been facilitated by the drop in the… Read more »
Obesity is becoming a common issue in most industrialized nations, with the prevalence in the United States, for instance, reaching over a third of the population, while deaths linked to obesity in the UK have risen dramatically, highlighting the important relationship between obesity and health. Diseases associated with obesity represent a significant medical and financial… Read more »
Dementia is a huge global health challenge. If dementia was a country it would be the 18th largest in terms of gross domestic product, listed between Turkey and Indonesia. 21st September marks World Alzheimer’s Day, and also celebrates the conclusion of the first World Alzheimer’s Month (WAM). “Dementia: Living together” is the theme of this… Read more »
Mammography screening programs are widely employed in Europe and the United States. In the UK, all women over the age of 50 are invited for screening every three years as part of the NHS breast screening programme. Screening is carried out in order to detect breast cancer at an early stage, so that treatment can… Read more »
The application of proteomic technologies to clinical specimens has the potential to revolutionize the treatment of many diseases. From biomarker discovery and validation to personalized therapies, proteomic techniques allow a greater understanding of the dynamic processes involved in disease, increasing the power of prediction, diagnosis and prognosis. The editors of Genome Medicine are now accepting… Read more »
The number of people affected by sepsis is staggering. The Global Sepsis Alliance (GSA) estimates that somewhere between 33% to 50% of all septic patients die because of the disease and that it will claim the lives of more than 6 million young children per year. Indeed, the GSA explains that sepsis kills more people… Read more »
Authors of study protocols in Systematic Reviews are now entitled to a 20% discount on the article processing charge (APC) for publication of the results of the same systematic review in the journal. Publication – and public registration in PROSPERO – of information about proposed or ongoing systematic reviews is increasingly common, and Systematic Reviews… Read more »
Fibrogenesis & Tissue Repair has published its first articles in its Cardiovascular Diseases thematic series; a collection of both research and review papers relating to all aspects of cardiac fibroproliferative disorders. In the series Editorial, Ian M.C. Dixon, Cardiovascular Section Editor for the journal and Editor of the thematic series, describes how the new series… Read more »
Alzheimer’s Research & Therapy is now accepting research submissions for a special series on cognitive enhancers for ageing and Alzheimer’s disease. Submit your manuscript to this series and receive a 50% article processing charge discount – simply quote ‘alzrtcog50’ at submission. Cognitive aging affects all of us. In the past few decades, there have been… Read more »